27.46
price up icon5.13%   1.34
 
loading
前日終値:
$26.12
開ける:
$26.21
24時間の取引高:
8.48M
Relative Volume:
0.77
時価総額:
$10.27B
収益:
$3.14B
当期純損益:
$-3.36B
株価収益率:
-3.1455
EPS:
-8.73
ネットキャッシュフロー:
$-4.03B
1週間 パフォーマンス:
+3.39%
1か月 パフォーマンス:
+12.40%
6か月 パフォーマンス:
-38.21%
1年 パフォーマンス:
-82.25%
1日の値動き範囲:
Value
$26.12
$27.55
1週間の範囲:
Value
$25.82
$28.57
52週間の値動き範囲:
Value
$23.15
$153.56

Moderna Inc Stock (MRNA) Company Profile

Name
名前
Moderna Inc
Name
セクター
Healthcare (1170)
Name
電話
(617) 714-6500
Name
住所
325 BINNEY STREET, CAMBRIDGE
Name
職員
5,800
Name
Twitter
@moderna_tx
Name
次回の収益日
2025-02-14
Name
最新のSEC提出書
Name
MRNA's Discussions on Twitter

MRNA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MRNA
Moderna Inc
27.46 10.27B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-13 開始されました Citigroup Neutral
2025-02-18 ダウングレード Barclays Overweight → Equal Weight
2025-01-29 ダウングレード Goldman Buy → Neutral
2024-12-18 ダウングレード Argus Buy → Hold
2024-12-10 再開されました BofA Securities Underperform
2024-11-19 開始されました Berenberg Hold
2024-11-18 アップグレード HSBC Securities Hold → Buy
2024-11-15 開始されました Wolfe Research Underperform
2024-10-17 開始されました Bernstein Mkt Perform
2024-09-13 ダウングレード JP Morgan Neutral → Underweight
2024-09-13 ダウングレード Jefferies Buy → Hold
2024-09-13 ダウングレード Oppenheimer Outperform → Perform
2024-08-28 アップグレード HSBC Securities Reduce → Hold
2024-08-07 アップグレード Deutsche Bank Sell → Hold
2024-08-05 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-02-26 ダウングレード HSBC Securities Hold → Reduce
2024-01-02 アップグレード Oppenheimer Perform → Outperform
2023-11-29 開始されました Canaccord Genuity Hold
2023-11-03 アップグレード HSBC Securities Reduce → Hold
2023-11-02 ダウングレード Deutsche Bank Hold → Sell
2023-08-04 ダウングレード TD Cowen Outperform → Market Perform
2023-08-03 ダウングレード Deutsche Bank Buy → Hold
2023-07-24 開始されました William Blair Mkt Perform
2023-07-14 開始されました HSBC Securities Reduce
2023-06-26 アップグレード UBS Neutral → Buy
2023-04-26 開始されました Guggenheim Neutral
2023-03-13 アップグレード TD Cowen Market Perform → Outperform
2023-03-02 開始されました RBC Capital Mkts Outperform
2023-02-24 ダウングレード SVB Securities Market Perform → Underperform
2022-12-19 アップグレード Jefferies Hold → Buy
2022-12-14 ダウングレード Chardan Capital Markets Buy → Neutral
2022-10-21 アップグレード SVB Leerink Underperform → Mkt Perform
2022-09-08 アップグレード Deutsche Bank Hold → Buy
2022-02-01 アップグレード Redburn Sell → Neutral
2022-01-26 アップグレード Deutsche Bank Sell → Hold
2022-01-21 アップグレード BofA Securities Underperform → Neutral
2022-01-21 開始されました UBS Neutral
2021-12-07 開始されました Cowen Market Perform
2021-11-09 開始されました Wolfe Research Outperform
2021-10-22 開始されました Deutsche Bank Sell
2021-10-15 アップグレード Piper Sandler Neutral → Overweight
2021-08-06 ダウングレード Oppenheimer Outperform → Perform
2021-08-06 ダウングレード Piper Sandler Overweight → Neutral
2021-07-15 繰り返されました Jefferies Hold
2021-02-01 ダウングレード BofA Securities Neutral → Underperform
2020-12-16 ダウングレード Jefferies Buy → Hold
2020-12-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-09 ダウングレード Needham Buy → Hold
2020-11-23 開始されました Wells Fargo Equal Weight
2020-11-17 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-09-08 ダウングレード SVB Leerink Mkt Perform → Underperform
2020-07-23 開始されました SVB Leerink Mkt Perform
2020-07-20 ダウングレード JP Morgan Overweight → Neutral
2020-07-13 開始されました Jefferies Buy
2020-06-30 開始されました Argus Buy
2020-06-08 開始されました Barclays Overweight
2020-04-30 開始されました BMO Capital Markets Outperform
2020-03-05 ダウングレード BofA/Merrill Buy → Neutral
2019-12-03 再開されました BofA/Merrill Buy
2019-10-25 開始されました ROTH Capital Buy
2019-04-05 開始されました Chardan Capital Markets Buy
すべてを表示

Moderna Inc (MRNA) 最新ニュース

pulisher
Jun 06, 2025

DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know - Yahoo

Jun 06, 2025
pulisher
Jun 06, 2025

Is Moderna Stock A Buy After Winning A Surprise Approval? - Investor's Business Daily

Jun 06, 2025
pulisher
Jun 06, 2025

Green Alpha Advisors LLC Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jun 06, 2025
pulisher
Jun 06, 2025

Moderna’s human/AI revampthe human implications and how to manage them - Diginomica

Jun 06, 2025
pulisher
Jun 06, 2025

How Is Moderna’s Stock Performance Compared to Other Biotechnology Stocks? - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

How Is Moderna’s Stock Performance Compared To Other Biotechnology Stocks? - Barchart.com

Jun 06, 2025
pulisher
Jun 06, 2025

Moderna, Inc. (NASDAQ:MRNA) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Trump administration cancels Moderna contract to fight bird flu and other viruses - news8000.com

Jun 05, 2025
pulisher
Jun 05, 2025

Moderna at Jefferies Conference: Strategic Growth and Challenges - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Fed Circ upholds Moderna’s COVID-19 vaccine win against Alnylam - Life Sciences Intellectual Property Review

Jun 05, 2025
pulisher
Jun 05, 2025

Moderna Beats Alnylam Appeal In COVID Vaccine Patent Case - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : Moderna, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 10 - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

Moderna’s HR-IT merger: Trend or exception to the rule? - cio.com

Jun 05, 2025
pulisher
Jun 04, 2025

Fed. Circ. Upholds Moderna's IP Win Over COVID Vax - Law360

Jun 04, 2025
pulisher
Jun 04, 2025

Alnylam Fails to Revive Patent Infringement Suit Against Moderna - Bloomberg Law News

Jun 04, 2025
pulisher
Jun 04, 2025

Strict Standard for Overriding Patent Lexicography in COVID Vaccine Patent Battle - Patently-O

Jun 04, 2025
pulisher
Jun 04, 2025

CAFC Affirms Moderna’s Win, Holding Alnylam Narrowly Defined ‘Branched Alkyl’ - IPWatchdog.com

Jun 04, 2025
pulisher
Jun 04, 2025

Class Action Filed Against Moderna, Inc. (MRNA) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 04, 2025

US appeals court sides with Moderna on COVID patent claims - Reuters

Jun 04, 2025
pulisher
Jun 04, 2025

Moderna Will Test New Covid Shot Against Placebo, RFK Jr. Says - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Moderna (MRNA) to Conduct New Trial for Next-Gen COVID Vaccine - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

RFK Jr. says Moderna agreed to another clinical trial to support new COVID shot - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

15,000 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Alpha Wealth Funds LLC - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Down 80%, Should You Buy the Dip on Moderna? - AOL.com

Jun 04, 2025
pulisher
Jun 03, 2025

Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says - whbl.com

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna will test new Covid shot against Placebo, Robert F Kennedy Jr. says - CNBC TV18

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna (MRNA) Will Test New Covid Shot Against Placebo, RFK Jr. Says - Bloomberg

Jun 03, 2025
pulisher
Jun 03, 2025

CDC official resigns from COVID vaccine committee advisory role, sources say - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

FDA grants limited approval to Moderna’s new mRNA COVID vaccine By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna's (MRNA) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike - Zacks Investment Research

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna (MRNA) Faces Challenges Amid Potential Regulatory Shifts | MRNA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna (NASDAQ:MRNA) Given Market Perform Rating at William Blair - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

How Moderna Went From Pandemic Hero to Vaccine Victim - WSJ

Jun 03, 2025
pulisher
Jun 03, 2025

Moderna (MRNA) Faces Challenges with mRNA Technology Focus | MRNA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Universal Beteiligungs und Servicegesellschaft mbH Takes $18.08 Million Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

LVW Advisors LLC Invests $298,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Lansforsakringar Fondforvaltning AB publ Invests $4.49 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

California State Teachers Retirement System Has $20.83 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jun 03, 2025
pulisher
Jun 02, 2025

HHS cancels funding for Moderna vaccines to fight pandemic flu - WATE 6 On Your Side

Jun 02, 2025
pulisher
Jun 02, 2025

What you need to know about Moderna’s new COVID vaccine, just approved by the FDA - AOL.com

Jun 02, 2025
pulisher
Jun 02, 2025

Market movers: Moderna, Cleveland Cliffs, Nucor, US Gold... - Proactive financial news

Jun 02, 2025
pulisher
Jun 02, 2025

FDA approves Moderna's new COVID-19 vaccine - CIDRAP

Jun 02, 2025
pulisher
Jun 02, 2025

Moderna (MRNA) Faces Multiple Regulatory Challenges - Insider Monkey

Jun 02, 2025
pulisher
Jun 02, 2025

Two biopharma stocks to consider outside of Moderna - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Moderna: Vaccine Approval (Finally!) Provides A Reason To Be Cheerful (NASDAQ:MRNA) - Seeking Alpha

Jun 02, 2025
pulisher
Jun 02, 2025

New Moderna COVID-19 vaccine approved by FDA for adults 65 and older - CBS News

Jun 02, 2025
pulisher
Jun 02, 2025

Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Moderna's COVID-19 vaccine mNEXSPIKE gains FDA approval - TechTarget

Jun 02, 2025
pulisher
Jun 02, 2025

Moderna moves higher on FDA approval of new COVID-19 vaccine - Proactive financial news

Jun 02, 2025
pulisher
Jun 02, 2025

Moderna's New Vaccine mNEXSPIKE Approved by FDA, Shares RiseNews and Statistics - IndexBox

Jun 02, 2025

Moderna Inc (MRNA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):